U.S. Banks Stock News

NYSE:LII
NYSE:LIIBuilding

Is Lennox International (LII) Undervalued As Strong Efficiency Metrics Draw Investor Attention?

Lennox International: Why Efficiency Metrics Are Back in Focus Fresh attention on Lennox International (LII) has been triggered by recent commentary highlighting its operating margin, free cash flow margin, and return on capital, which together are drawing closer scrutiny from investors. See our latest analysis for Lennox International. Lennox International's recent share price has come under pressure, with the 30 day share price return down 25.55% and the year to date share price return down...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Does ImmunityBio’s (IBRX) Jim Yong Kim Hire Transform Its Global Access Strategy For Immunotherapies?

ImmunityBio, Inc. recently appointed former World Bank president Dr. Jim Yong Kim as Vice Chairman, placing him in a newly created Office of the Executive Chairman to focus on global relationships with governments, health ministries, multilateral institutions, and other health partners. This move brings deep global health and development expertise directly into ImmunityBio’s leadership, potentially reshaping how the company pursues international access to its immunotherapy platform and...
NYSE:INGR
NYSE:INGRFood

3 Defensive Dividend Stocks for Higher Rates and Steady Income

With Treasury yields high, inflation still above 3% and the Federal Reserve’s next steps under close watch at Jackson Hole, investors are again questioning how much risk they really want to take. That uncertainty is pushing more attention toward high quality dividend stocks in defensive sectors that may handle prolonged higher rates differently. This article reveals three stocks exposed to these macro shifts and explains why each one could deserve a closer look right now. The stocks covered...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Alnylam (ALNY) Stock May Look Rich On Earnings Despite Weaker Price Action

Alnylam Pharmaceuticals has had a difficult run over the past year, with the share price down 46.8%, while the current valuation checks still lean toward the stock being on the expensive side rather than a clear bargain. Over the past 12 months, Alnylam Pharmaceuticals shareholders have seen the stock decline 46.8%, which puts a spotlight on whether earlier optimism was too strong. Upcoming clinical data on RNAi programs like the transthyretin and hypertension studies can support sentiment...
NasdaqGS:MAT
NasdaqGS:MATLeisure

How Investors May Respond To Mattel (MAT) Expanding Into Premium Xbox Collectibles And Tournament-Style UNO

In August 2026, Mattel announced a 3,509-piece, 1:1-scale buildable model of the original Microsoft XBOX under its Mattel Brick Shop premium brand, alongside new UNO Championship Series products that turn the classic card game into a competitive, tournament-style experience for home play. By pairing an adult-focused, high-end gaming collectible with a refreshed competitive format for one of its best-known family games, Mattel is broadening its reach across gamers, collectors, and large-group...
NasdaqGS:UMBF
NasdaqGS:UMBFBanks

UMB Financial (UMBF) Beat Expectations, But Is The Stock Still Cheap?

UMB Financial (UMBF) reported a strong second quarter, with revenue and earnings above expectations, supported by loan growth, solid asset quality, and higher fee income from monetizing investments. Despite this, the stock price reaction remained muted. See our latest analysis for UMB Financial. At a share price of US$145.14, UMB Financial has delivered a 24.61% year to date share price return. The 1 year total shareholder return of 22.10% and the very strong 3 year total shareholder return...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Ascendis Pharma (ASND) On Profitability, The Valuation Narrative Still Points To Upside

Ascendis Pharma earnings event and why it matters for shareholders Ascendis Pharma (NasdaqGS:ASND) recently reported second quarter 2026 results, with sales of €339.29 million and net income of €206.97 million, following a net loss in the same period a year earlier. See our latest analysis for Ascendis Pharma. Following the strong second quarter earnings shift into profitability, Ascendis Pharma's 7 day share price return of 2.38% and 90 day share price return of 5.69% suggest momentum has...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos Holdings (LDOS) Lands $301 Million Cyber Contract, Is The Stock Still Undervalued?

Leidos Holdings (LDOS) has secured a new five year, US$301 million contract to monitor U.S. military networks around the clock. The work extends its role in cyber defense for the Department of War. See our latest analysis for Leidos Holdings. At a share price of US$141.39, Leidos Holdings has seen a 30 day share price return of 26.08% and a 90 day share price return of 10.36%, while the 1 year total shareholder return is down 21.33% but up just over 50% across three and five years. This...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash (DASH) Could Be 9% Undervalued As Retail Partnerships Widen Its Marketplace

DoorDash (DASH) has been in focus after new partnerships with Barnes & Noble, Carter's, Kohl's, and Gap expanded its Marketplace into books, apparel, and broader back to school essentials for same day delivery. See our latest analysis for DoorDash. The latest partnerships come as DoorDash’s share price has gained momentum, with a 30 day share price return of 29.25% and a 90 day share price return of 45.12%, even though the 1 year total shareholder return declined 8.88% while the 3 year total...
NYSE:ESNT
NYSE:ESNTDiversified Financial

Is Essent Group (ESNT) Fairly Valued Or Is More Upside Still In View?

Recent trading snapshot and return profile Essent Group (ESNT) recently closed at US$68.07, with the stock down about 0.7% on the day and 2% over the past week, yet up in the past month and past 3 months. For longer term holders, Essent Group shows a 10.4% total return over the past year, with multi year total returns above 40% over 3 years and above 60% over 5 years. See our latest analysis for Essent Group. For context, Essent Group’s short term share price momentum has cooled slightly...
NYSE:CMG
NYSE:CMGHospitality

Is Chipotle Mexican Grill (CMG) Fully Valued On Its First Saudi Arabia Opening?

Chipotle Mexican Grill (CMG) is drawing investor attention after announcing its first restaurant in Saudi Arabia later this month, in partnership with Alshaya Group. The move extends a growing presence across the Middle East. See our latest analysis for Chipotle Mexican Grill. The Saudi Arabia opening comes after a period of solid short term momentum for Chipotle Mexican Grill, with a 1 month share price return of 16.07% and a 90 day share price return of 14.21%, even as the 1 year total...
NYSE:V
NYSE:VDiversified Financial

Visa (V) Stock May Be 8% Undervalued Despite DOJ Trial Clash

Visa stock has delivered a strong 66.7% return over the past 5 years, yet current checks suggest it no longer looks clearly cheap. The intrinsic value estimate from the Excess Returns model is broadly in line with the market price, while earnings-based multiples lean expensive. Recent news around antitrust litigation and new payment initiatives means investors are weighing solid past gains against what they are now paying for Visa’s future cash flows. A 66.7% gain over 5 years frames Visa as...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine Biosciences (NBIX) Stock Still Looks Like A Bargain Following Its 59% Run

Neurocrine Biosciences stock has delivered a 59.0% return over the past five years, yet its current valuation checks still lean on the cheap side rather than pricing in a clear premium. That mix of solid long term performance and a strong value read is what investors now need to weigh. Over the past 5 years, Neurocrine Biosciences has returned 59.0%, which puts recent share price moves in the context of a stock that has already created meaningful value for long term holders. Fresh data from...
NasdaqGS:CASH
NasdaqGS:CASHBanks

Is Pathward Financial (CASH) Undervalued Following Its Dividend Affirmation?

Dividend affirmation sets the stage for Pathward Financial stock discussion Pathward Financial (CASH) has affirmed a quarterly cash dividend of $0.05 per share for its fourth fiscal quarter of 2026, payable on October 1 to shareholders of record on September 10. See our latest analysis for Pathward Financial. Alongside the dividend affirmation, Pathward Financial’s recent trading has been steady rather than sharp, with the share price at US$83.68 and a year to date share price return of...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Stock Looks Above Fair Value On Sales But Strong On Returns

Moderna stock has surged over the past year, yet the company currently screens as expensive on Simply Wall St's broader valuation checks. This raises questions about how much of the good news is already reflected in the share price. Moderna has returned 472.5% over the past year, which puts recent optimism at the center of any discussion about what investors are now paying for future cash flows. The recent positive Phase 3 melanoma vaccine results can support higher long term growth...
NYSE:WHR
NYSE:WHRConsumer Durables

Is Whirlpool (WHR) Undervalued On Revenue Declines And Leverage Concerns?

Recent commentary around Whirlpool (WHR) has focused on declining revenue, weaker earnings, and a relatively high net-debt-to-EBITDA ratio. Together, these factors are raising fresh investor concerns as customers delay major appliance purchases. See our latest analysis for Whirlpool. Whirlpool’s share price has recently shown a short burst of strength, with a 1-month share price return of 8.26% and a 7-day gain of 1.92%. However, this follows a much steeper reset that leaves the year-to-date...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Is Sunrun (RUN) Quietly Recasting Its Residential Solar Story Around AI-Driven Grid Services?

On 17 August 2026, Sunrun Inc. announced an agreement with Voltus Inc. to supply energy capacity from its residential solar-plus-storage fleet in the PJM and MISO regions to support Voltus’s Bring Your Own Capacity programs for AI hyperscalers. The collaboration highlights how Sunrun is turning thousands of home batteries and smart devices into a virtual power resource that can earn payments for participants while supporting data-center-driven grid demand. Next, we’ll examine how channeling...
NYSE:O
NYSE:ORetail REITs

What Realty Income (O)'s New Convertible Notes and Steady Dividend Mean For Shareholders

Earlier this month, Realty Income Corporation declared its 674th consecutive monthly common stock dividend of US$0.2710 per share, annualized at US$3.252, payable on September 15, 2026 to stockholders of record as of August 31, 2026. Away from its long-running income payouts, Realty Income has also completed and announced sizeable convertible senior note offerings due 2031, reshaping its funding mix and adding a new layer of capital structure complexity for investors to assess. We’ll now...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

LKQ (LKQ) Stock Still Offers A Discount On Earnings Strength

LKQ stock has had a difficult run over the last few years, yet current valuation checks still suggest the shares lean cheap rather than expensive. The question for investors is whether that gap between weak past returns and a stronger valuation profile is justified. LKQ has declined 45.3% over the last 3 years, which signals that the market has taken a much more cautious view of the stock. Future cash generation and margin resilience can support the current market value, while any setback in...
NYSE:STE
NYSE:STEMedical Equipment

STERIS (STE) Rebound Puts Its Undervalued Narrative To The Test

STERIS (STE) stock has recently drawn attention after its latest share price move, with the company closing at $237.93 on 19 August 2026. Investors are weighing this valuation against its recent performance and financial profile. See our latest analysis for STERIS. Over the past month STERIS has seen an 11.15% 1 month share price return and a 10.02% 3 month share price return, although the year to date share price return is down 4.84% and the 1 year total shareholder return is down 3.23%...
NYSE:ESS
NYSE:ESSResidential REITs

Essex Property Trust (ESS) Gains Attention As Supply Slows, Is The Stock Getting Expensive?

Why Essex Property Trust Is Back On Investors’ Radar Essex Property Trust (ESS) is drawing attention as apartment development slows and residential REIT fundamentals in its West Coast markets improve, with occupancy and resident retention helping support rental income stability. These conditions come alongside pockets of earnings volatility linked to weak new lease pricing and excess supply in some areas, which keeps the risk return trade off in focus for investors assessing the stock...
NYSE:DVN
NYSE:DVNOil and Gas

Devon Energy (DVN) Backs Solitude Pipeline System, Is The Stock Still A Bargain?

Devon Energy (DVN) has put a spotlight on its gas infrastructure plans after approving the Solitude Pipeline System, a joint venture to build two major Permian to Katy natural gas pipelines. See our latest analysis for Devon Energy. Recent moves like the Solitude Pipeline decision come as Devon Energy’s share price has gained momentum, with a 30 day share price return of 9.01% and a year to date share price return of 29.65%. Over the past year, total shareholder return of 40.83% and 111.19%...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal (HCC) Stock May Be A Bargain After Blue Creek Progress

Warrior Met Coal stock has delivered a very strong 442.3% return over the past 5 years, while the current valuation checks send a mixed message with a low overall value score but an intrinsic value estimate from a Discounted Cash Flow (DCF) suggesting the shares trade at a sizeable discount to that estimate. The 442.3% 5 year return shows Warrior Met Coal has already rewarded long term holders in a big way. Ramping production at the low cost Blue Creek mine can support cash flow, although...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Arm Stock And 2 Robotics Picks For The Automation Buildout

Robotics and automation are back in the spotlight as Eurozone services activity stays robust, with August PMI readings holding near multi year highs, supported by tourism and external demand. Companies everywhere are under pressure to do more with tight labor markets and rising costs, which keeps automation firmly on the agenda. This article walks through 3 Robotics and Automation Stocks screener picks that capture this potential. The stocks covered below are just a starting sample, and the...